Abu Dhabi closed the door on 2026 Emiratisation adjustments at 31 December. The shortfall carries forward, and the penalty list ends with exclusion from the payer network.
DoH Circular 164/2026, issued 25 August 2026, fixes 31 December 2026 as the final date for every recruitment and licensing step counting toward a facility's 2026 Emiratisation target. After it, no additions, amendments, pending applications or retrospective adjustments are considered. Non-compliance runs to financial penalties, administrative suspension of the facility licence, suspension of adding new services, or exclusion from the Daman-Thiqa network, and any shortfall is carried into 2027 and assessed cumulatively. For a buyer, that turns a target's Emiratisation gap from a compliance footnote into an inherited liability with a compounding schedule.
What a board member needs before the next meeting on this.
- The deadline is 31 December 2026 and it closes the file. Facilities must complete all recruitment procedures, including the relevant licensing processes, before that date. The circular states that after it, no additions, amendments, pending applications, retrospective adjustments or other modifications will be considered for the purpose of calculating or fulfilling the 2026 targets.
- The penalty list reaches the payer network. The circular names four regulatory actions for non-compliance: financial penalties under the applicable disciplinary regulations, administrative suspension of facility licences, suspension of the addition of new services, and exclusion of the facility from the Daman-Thiqa network.
- A shortfall is cumulative, not annual. Any shortfall against the 2026 targets is carried forward to 2027 and assessed on a cumulative basis. A facility that misses this year must achieve its 2027 targets in addition to addressing the outstanding 2026 gap.
- Targets cover administrative roles, not only clinical ones. The circular requires facilities to achieve their assigned 2026 targets across both clinical and administrative categories, so a facility cannot close a gap by treating the requirement as a clinical-hiring problem alone.
On 25 August 2026 the Department of Health – Abu Dhabi issued Circular No. (164) 2026, "Reinforcement of 2026 Tawteen Year-End Targets, Cut-off and Compliance Measures", addressed to all healthcare and pharmaceutical facilities and following Circular No. (47) 2026 and the circulars referenced in it (DoH Circular 164/2026; DoH circulars index). Most operators will read it as a reminder about Emiratisation quotas. The two provisions at the end of it are what matter to anyone buying, lending against, or sitting on the board of an Abu Dhabi facility.
The file closes on 31 December and nothing reopens it
The circular requires facilities to complete all recruitment procedures, including the relevant licensing processes, before a final deadline of 31 December 2026. The operative language is what follows that date: no additions, amendments, pending applications, retrospective adjustments or other modifications will be considered for the purpose of calculating or fulfilling the 2026 targets. Facilities routinely close a quota gap in the last weeks of the year by counting signed offers and licence applications in flight.
This circular forecloses that. A candidate who has accepted but whose DoH licensing has not completed by 31 December does not count, and there is no route to correct the position in January. The practical deadline for hiring is therefore earlier than 31 December, and it falls whenever the licensing queue for a given professional category stops clearing in time to land before it.
The penalty list ends at the payer network
The circular states that facilities found non-compliant after the deadline will be subject to the applicable regulatory actions and measures, and it names them: financial penalties in accordance with the applicable disciplinary regulations, administrative suspension of facility licences, suspension of the addition of new services, and exclusion of the facility from the Daman-Thiqa network.
The first three are costs. The fourth belongs to a different category of event. For an Abu Dhabi provider, Thiqa is the payer for the UAE national population, and exclusion from that network removes a revenue line rather than taxing it.
A board that has modelled Emiratisation non-compliance as a fine has modelled the least severe item on a list of four. The suspension of new-service additions deserves separate attention in a growth case: a facility part-way through a service-line expansion that misses its target cannot add the service the expansion capital was raised to build.
The shortfall compounds into 2027
The provision that changes the arithmetic is the carry-forward. Any shortfall against the 2026 targets is carried forward to 2027 and assessed on a cumulative basis, so a facility that misses will be required to achieve its 2027 targets in addition to addressing the outstanding 2026 gap.
Emiratisation exposure is an accumulating obligation rather than an annual compliance charge that resets each January. The hiring requirement in the following year is the sum of the new target and the old miss. A facility two years behind carries one obligation that has roughly doubled, while the pool of licensed Emirati candidates in its specialty has not grown to match.
What this does to a diligence read
Workforce is the largest line in most healthcare operating models, and this circular attaches a dated, compounding, licence-level consequence to it. For a buyer, the target's Emiratisation position stops being a representation to collect and becomes a number to verify against actual licensed headcount on the day of signing, category by category, clinical and administrative.
A seller presenting the position as on track while several counted hires sit in a licensing queue is describing a target that will miss and carry the miss into the year the buyer owns it. The cost that lands on the buyer is the salary bill for hiring into a constrained national talent pool, at whatever clearing price applies once every other facility in the emirate has spent the fourth quarter competing for the same candidates.
Against that, the penalty is the smaller number. The circular's own routing shows who inside DoH owns the question: the Healthcare Facilities Licensing Division, the Healthcare Regulations and Sustainability Division, and the Healthcare System Financing Regulation Sector, which is also the sector that owns Thiqa.
Four questions before signing on an Abu Dhabi provider
- What is the target's assigned 2026 Emiratisation figure, split across clinical and administrative categories, and where does it stand against actual licensed headcount today rather than against offers outstanding?
- Are any of the recruitments the seller counts toward the 2026 target still awaiting a licensing step, given that the licensing process itself must complete before 31 December?
- If the target misses, what does the 2027 obligation become once the carried-forward shortfall is added, and is that hiring volume achievable in the local market at the salary assumed in the model?
- What share of the target's revenue depends on the Daman-Thiqa network, and what would exclusion from it do to the business over a single quarter?
The Monday work is finite. Pull the target's assigned 2026 figure by category and lay actual licensed headcount alongside it, counting only professionals whose DoH licensing has completed. Age every pending recruitment against the licensing queue for its category and mark which will not land before 31 December.
Then price two things separately: the remediation cost of the 2027 obligation with the 2026 shortfall added, and the revenue consequence of the Thiqa exclusion the circular puts on the table. That workforce and regulatory diligence is where our buy-side M&A practice begins.
This brief covers one instrument. The UAE healthcare regulatory tracker carries the full set — DoH, DHA, EDE and the other emirates — with what each one changes and when it takes effect.
Subscribe
The UAE healthcare regulatory briefing
What changed, what it reprices, and the instrument to read. Every second Tuesday. No pitches.
One email a fortnight. Unsubscribe from any of them.